NDC 36987-3413

Saltbush

Saltbush

Saltbush is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Nelco Laboratories, Inc.. The primary component is Atriplex Wrightii Pollen.

• Product ID: 36987-3413_45a21265-75ff-4634-a154-faff541e45d6
• NDC: 36987-3413
• Product Type: Human Prescription Drug
• Proprietary Name: Saltbush
• Generic Name: Saltbush
• Dosage Form: Injection, Solution
• Route of Administration: INTRADERMAL; SUBCUTANEOUS
• Marketing Start Date: 1972-08-29
• Marketing Category: BLA / BLA
• Application Number: BLA102192
• Labeler Name: Nelco Laboratories, Inc.
• Substance Name: ATRIPLEX WRIGHTII POLLEN
• Active Ingredient Strength: 10000 [PNU]/mL
• Pharm Classes: Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS]
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 36987-3413-2

10 mL in 1 VIAL, MULTI-DOSE (36987-3413-2)

• Marketing Start Date: 1972-08-29
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 36987-3413-2 [36987341302]

Saltbush INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102192
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1972-08-29
• Inactivation Date: 2019-10-21

NDC 36987-3413-3 [36987341303]

Saltbush INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102192
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1972-08-29
• Inactivation Date: 2019-10-21

NDC 36987-3413-1 [36987341301]

Saltbush INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102192
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1972-08-29
• Inactivation Date: 2019-10-21

NDC 36987-3413-4 [36987341304]

Saltbush INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102192
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1972-08-29
• Inactivation Date: 2019-10-21

Drug Details

Active Ingredients

Ingredient	Strength
ATRIPLEX WRIGHTII POLLEN	10000 [PNU]/mL

OpenFDA Data

• SPL SET ID: 98bdde2e-6f04-4ff4-a6e3-1348d31c1bb1
• Manufacturer:
  • Nelco Laboratories, Inc.
• UNII:
  • U2AI3H2J5Y
  • 92N6W6KO2G
  • 2A64U81OQ3
  • 68R9X9Y96X
  • 098LKX5NCN
  • 380W4HYR6N
  • YB1308W43O
  • 644CZ16IR5
  • BBO1IJ3ZIW
  • DO87T1U2CI
  • YI19RB8YFD
  • JQ87AA60GU
  • 6532U64A3X
  • 81GS97HVFO
  • RX18M46K8L
  • 86LWA5503I
  • 2MH135KC6G
  • 5W6JAI84OI
  • V825XJG64G
  • 1GH3WV23KH
  • 2QOF601J1M
  • WIB701MW2H
  • WQ3S5294XY
  • N52MIQ81ZW
  • O4AB4546TP
  • DNB59M1NVU
  • 26U0BU8G83
  • B67NF86HF0
  • 57KIJ4772H
  • ANT994T71D
  • KU1V1898XX
  • 13KFG30UBR
  • 73B14PX5FW
• RxNorm Concept Unique ID - RxCUI:
  • 897963
  • 897311
  • 897398
  • 896167
  • 1013980
  • 1006363
  • 896286
  • 1006484
  • 895610
  • 895675
  • 896205
  • 897372
  • 896123
  • 1013984
  • 896182
  • 896261
  • 896086
  • 897993
  • 897955
  • 897973
  • 901473
  • 897323
  • 1006355
  • 896296
  • 896154
  • 895723
  • 308004
  • 1006490
  • 895909
  • 896076
  • 897947
  • 896277
  • 896253
  • 897510
  • 897380
  • 898335
  • 897339

Pharmacological Class

• Non-Standardized Pollen Allergenic Extract [EPC]
• Increased Histamine Release [PE]
• Cell-mediated Immunity [PE]
• Increased IgG Production [PE]
• Pollen [CS]
• Allergens [CS]

NDC Crossover Matching brand name "Saltbush" or generic name "Saltbush"

NDC	Brand Name	Generic Name
36987-3413	Saltbush	Saltbush
36987-3414	Saltbush	Saltbush
36987-3415	Saltbush	Saltbush
36987-3416	Saltbush	Saltbush
36987-3417	Saltbush	Saltbush
36987-3418	Saltbush	Saltbush
36987-3419	Saltbush	Saltbush
36987-3420	Saltbush	Saltbush